
Health Care Technology
Axtria And Genloop Deliver Domain-Trained Llms: Advancing Agentic AI In Life Sciences With Enhanced Accuracy, Flexibility, And Cost Efficiency
By PR Newswire

BERKELEY HEIGHTS, N.J., May 15, 2025 /PRNewswire/ -- Axtria Inc., a global leader in AI-powered data analytics solutions for the life sciences industry, is collaborating with Genloop to help life sciences organizations navigate the complex landscape of agentic AI. The collaboration combines Axtria's deep industry and data analytics expertise with Genloop's specialized large language models (LLMs) to address the unique challenges life sciences companies face when implementing agentic solutions. The collaboration enhances Axtria's new Axtria InsightsMAx.ai platform and consulting services.
"Life sciences organizations have unique needs that make it difficult to adopt generic AI solutions. Genloop addresses this by injecting institutional understanding into LLMs—delivering personalized models that continuously learn from task practice and feedback," said Ayush Gupta, CEO, Genloop. "We're excited to exclusively team with Axtria to provide domain-specific LLMs that understand the complexities of life sciences."
Axtria and Genloop overcome common barriers to successful migration of agentic AI – from implementation to production – by offering:
- Industry-Specific Knowledge Gaps: Ensuring Agentic AI solutions understand the nuanced context of life sciences
- Regulatory Compliance Requirements: Navigating the strict regulatory environment with confidence
- Enterprise System Connectivity: Seamlessly integrating scalable Agentic AI capabilities with existing infrastructure
- Specialized Expertise: Combining AI and life sciences knowledge
"This collaboration is about being a trusted partner for life sciences companies as they explore the transformative potential of Agentic AI," said Lokesh Jindal, Head of Products at Axtria. "We're focused on creating Agentic AI pathways that enhance organizational decision-making, ensuring agents accurately interpret and return data in the correct business context."
This collaboration offers life sciences companies:
- Contextual Understanding: Agentic solutions that understand industry-specific terminology and processes
- Data Security: Privately hosted models that safeguard sensitive information
- Enhanced Precision: Domain knowledge that improves accuracy and relevance
- Adaptive Learning: Systems that evolve through ongoing use
- Flexible Implementation: Solutions that work with existing enterprise data systems
- Trusted Performance: Comprehensive testing to ensure reliability and compliance
- Predictable Costs: Fixed total cost of ownership compared to generic solutions
For more information about how Axtria can support your organization's AI journey, please visit www.axtria.com.
About Genloop
Genloop specializes in helping enterprises develop their domain-specialized large language models (LLMs) that understand their business and can be reliably used in enterprise applications. The company's platform enables organizations to build their AI with minimal development effort and leverage significant benefits in cost, control, and performance.
About Axtria's Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx.ai is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.
About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/axtria-and-genloop-deliver-domain-trained-llms-advancing-agentic-ai-in-life-sciences-with-enhanced-accuracy-flexibility-and-cost-efficiency-302456631.html
SOURCE Axtria, Inc.
Frequently Asked Questions
What is agentic AI?
Agentic AI refers to AI systems that can independently perform tasks and make decisions to achieve specific goals, learning and adapting as they go.
What benefits does this collaboration provide to life sciences companies?
This collaboration provides contextual understanding, data security, enhanced precision, adaptive learning, flexible implementation, trusted performance, and predictable costs for AI solutions.
What is Axtria InsightsMAx.ai?
Axtria InsightsMAx.ai is Axtria's agentic platform, featuring agents, apps, and APIs, along with an experimentation environment for creating AI solutions for unique business challenges.
First published on Fri, May 16, 2025
Liked what you read? That’s only the tip of the tech iceberg!
Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!
Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.
Dive into TechDogs' treasure trove today and Know Your World of technology like never before!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Cloudzero Launches Optimize To Cut Waste, Boost Cloud ROI
By PR Newswire
Cognizant Recognized As Pega Partner Of The Year For Advancing AI-Powered Enterprise Transformation
By PR Newswire
DXC Relaunches SAP Fast RISE Offering In Mexico, Powered By Microsoft Azure, To Accelerate Secure And Local Digital Transformation
By PR Newswire
Iquanti Announces CEO Transition, Welcomes Arnab Sen As Chief Executive Officer
By PR Newswire
Lummus Completes Acquisition Of NAPCON From Neste, Expanding Digital And AI Capabilities
By PR Newswire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion